Dermapharm Holding SE:
Dermapharm Holding SE / Key word(s): Investment
Disclosure of insider information pursuant to Section17 (1) 1 of the EU Regulation
Dermapharm Holding SE acquires a stake in fitvia
Grünwald, June 06, 2019 - Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D8) via Dermapharm AG concluded an agreement today to acquire a majority stake in fitvia GmbH, a company headquartered in Wiesbaden, Germany. With closing of the transaction, Dermapharm AG is acquiring 70.00 percent of the shares in the company specialized in healthy nutrition. The parties have agreed not to disclose the purchase price.
The purchase agreement is still subject to the approval of the antitrust authority. The Management Board expects the transaction to be completed in the third quarter of 2019.
>End of ad hoc announcement<
06-Jun-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||Dermapharm Holding SE|
|Phone:||+49 (0)89 64 86-0|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange|
|EQS News ID:||820967|
|End of Announcement||DGAP News Service|